BrainAurora-B Rises After Schizophrenia Training Study Published In npj Digital Medicine

BrainAurora-B (06681) rose 3.8% to HK$1.49, with about 930,000 shares traded for HK$1.37 million, according to ETNet. The company said a study on adaptive cognitive training for schizophrenia, jointly conducted by a team led by Professor Wang Gang of Beijing Anding Hospital, Capital Medical University, and the group's research team, has been published in the journal npj Digital Medicine. BrainAurora-B said the main findings included faster and stronger cognitive improvement. A linear mixed-effects model showed the adaptive group achieved greater and quicker gains in attention and processing speed/agility, while the adaptive group's continuous performance test and MCCB total score were both significantly better than the control group. Positive symptoms also improved significantly.